RE:I know what CXR guidedfdfd12 wrote:
Sorry guys but this AMCO 2014 report caught me by surprise.
Why only 76M in profit with $450 rev.
Fdfd12:
I get the feeling that you are trying to cast doubt for your own personal gain. I may be wrong, but . . . anyways, you are trying to reconcile AMCo's 2014 actual results with 2016 CXR forecasts. Have you stopped to consider:
10 feb 15 AMCo launches Dexamethasone 10mg/5ml & 20mg/5ml SF Oral Solution x 50ml steroid. AMCo is delighted to announce the launch of two unique pharmaceutical products to the UK market – Dexamethasone 10mg/5ml & Dexamethasone 20mg/5ml steroid.
12 feb 15 AMCo launches Metformin 500mg/5ml Oral Solution x 150ml for diabetes. AMCo is delighted to announce the launch of Metformin Oral Solution. It will be launched by the Focus Pharma division of AMCo. This product is indicated to treat type II diabetes, a fast growing health issue within the UK.
19 mar 15 AMCo has launched Pevanti® AMCo has launched Pevanti® – a new branded range of prednisolone tablets for the treatment of a wide range of inflammatory and auto-immune conditions.
16 apr 15 AMCo launches Voleze® Rivastigmine 13.3mg/24hr Transdermal Patches AMCo is delighted to announce the launch of Voleze® 13.3mg Transdermal patches
16 apr 15 AMCo launches Cilostazol 100mg Tablets AMCo is delighted to announce the launch of Cilostazol 100mg tablets
05 may 15 AMCo opens office in Dubai to provide more medicines to the Middle East AMCo has opened an office in Dubai to make more of its medicines available to doctors, hospitals and healthcare professionals in the Middle East. The country will become the hub for AMCo’s expansion into the region and North Africa, including Saudi Arabia and Algeria.
02 jun 15 AMCo acquisition of Primegen AMCo is delighted to announce the acquisition of Primegen Limited ("Primegen"), a speciality pharma business in the UK. Primegen sells a number of niche medicines, predominantly in the UK, and has an attractive pipeline of UK and international registrations.
14 jul 15 AMCo acquires Australian company Boucher and Muir AMCo has acquired the Australian pharmaceutical company, Boucher and Muir (‘BNM’).
I believe that anyone who sincerely wants to estimate 2015 or 2016 operating results will want to factor in all available information that might be relevant to those years. Have you? I have 25 years of working with financial information, as a professional, and I wouldn't even attempt to try to estimate AMCo's 2015 operating results.